scholarly journals Development and validation of an Onchocerca ochengi adult male worm gerbil model for macrofilaricidal drug screening

2019 ◽  
Vol 13 (7) ◽  
pp. e0007556 ◽  
Author(s):  
Fidelis Cho-Ngwa ◽  
Glory Enjong Mbah ◽  
Rene Bilingwe Ayiseh ◽  
Emmanuel Menang Ndi ◽  
Elvis Monya ◽  
...  
1998 ◽  
Vol 92 (6) ◽  
pp. 711-720 ◽  
Author(s):  
H. F. Cross ◽  
A. Renz ◽  
A. J. Trees

Cancer ◽  
2013 ◽  
Vol 120 (4) ◽  
pp. 589-602 ◽  
Author(s):  
Katja Karjalainen ◽  
Renata Pasqualini ◽  
Jorge E. Cortes ◽  
Steven M. Kornblau ◽  
Benjamin Lichtiger ◽  
...  

2021 ◽  
Vol 8 (02) ◽  
pp. e56-e61
Author(s):  
Alexis Sylvain Wafo Mbobda ◽  
Alain Wembe Ngouonpe ◽  
Gervais Mouthé Happi ◽  
Bel Youssouf G. Mountessou ◽  
Elvis Monya ◽  
...  

AbstractA new flavone derivative named pachypodostyflavone (1), along with 8 known compounds (2–9) and a mixture of β-sitosterol and stigmasterol were isolated from the stem bark of Duguetia staudtii (Annonaceae), based on a bioassay-guided fractionation. Their structures were determined using high-resolution mass spectrometry and NMR spectroscopic data, as well as by comparison with the literature values of their analogs. Selected isolated compounds were evaluated for their in vitro antifilaricidal activities on Onchocerca ochengi microfilariae and adult worms. Inhibition of motility was evaluated spectroscopically on microfilaria and adult male worms. Viability was determined on adult female worms by the MTT/ Formazan assay. Auranofin at 10 µM and 2% DMSO were used as positive and negative controls, respectively. Compounds 1 and 7 showed potent anti-onchocerca activities with 100% activity at 250 µg/mL on both O. ochengi adult male and female worms, while compound 5 displayed 100% activity at 30 µg/mL.


2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Djafsia Boursou ◽  
Dieudonné Ndjonka ◽  
Albert Eisenbarth ◽  
Kingsley Manchang ◽  
Archille Paguem ◽  
...  

2015 ◽  
Vol 9 (1) ◽  
pp. e0003484 ◽  
Author(s):  
Cristiana Lalli ◽  
Alessandra Guidi ◽  
Nadia Gennari ◽  
Sergio Altamura ◽  
Alberto Bresciani ◽  
...  

Author(s):  
Itaru Watanabe ◽  
Dante G. Scarpelli

Acute thiamine deficiency was produced in mice by the administration of oxythiamine, a thiamine analogue, superimposed upon a thiamine deficient diet. Adult male Swiss mice (30 gm. B.W.) were fed with a thiamine deficient diet ad libitumand were injected with oxythiamine (170 mg/Kg B.W.) subcutaneously on days 4 and 10. On day 11, severe lassitude and anorexia developed, followed by death within 48 hours. The animals treated daily with subcutaneous injections of thiamine (300 μg/Kg B.W.) from day 11 through 15 were kept alive. Similarly, feeding with a diet containing thiamine (600 μg/Kg B.W./day) from day 9 through 17 reversed the condition. During this time period, no fatal illness occurred in the controls which were pair-fed with a thiamine deficient diet.The oxythiamine-treated mice showed a significant enlargement of the liver, which weighed approximately 1.5 times as much as that of the pair-fed controls. By light and electron microscopy, the hepatocytes were markedly swollen due to severe fatty change and swelling of the mitochondria.


Sign in / Sign up

Export Citation Format

Share Document